The goal of this activity is for learners to be better able to individualize care for patients with advanced NSCLC who are eligible for treatment with immunotherapy as part of the interprofessional team.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1000760
- Start Date: 2024-05-03 05:00:00
- End Date: 2024-05-03 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 11644.0 - Is Kind Support: False Source: Novocure - Amount: 5590.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology, Pulmonary Disease
Subscribe
Login
0 Comments
Oldest